CL2014002658A1 - Composición inmunogénica que comprende proteínas de la membrana exterior de histophilus somni; usos y sus métodos de preparación. - Google Patents

Composición inmunogénica que comprende proteínas de la membrana exterior de histophilus somni; usos y sus métodos de preparación.

Info

Publication number
CL2014002658A1
CL2014002658A1 CL2014002658A CL2014002658A CL2014002658A1 CL 2014002658 A1 CL2014002658 A1 CL 2014002658A1 CL 2014002658 A CL2014002658 A CL 2014002658A CL 2014002658 A CL2014002658 A CL 2014002658A CL 2014002658 A1 CL2014002658 A1 CL 2014002658A1
Authority
CL
Chile
Prior art keywords
preparation
methods
immunogenic composition
outer membrane
membrane proteins
Prior art date
Application number
CL2014002658A
Other languages
English (en)
Inventor
Brice Dean Lilly
Jeffrey P Knittel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CL2014002658A1 publication Critical patent/CL2014002658A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
CL2014002658A 2012-04-05 2014-10-02 Composición inmunogénica que comprende proteínas de la membrana exterior de histophilus somni; usos y sus métodos de preparación. CL2014002658A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261620652P 2012-04-05 2012-04-05
US13/796,653 US9597386B2 (en) 2012-04-05 2013-03-12 Outer membrane proteins of Histophilus somni and methods thereof

Publications (1)

Publication Number Publication Date
CL2014002658A1 true CL2014002658A1 (es) 2015-03-20

Family

ID=49292471

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002658A CL2014002658A1 (es) 2012-04-05 2014-10-02 Composición inmunogénica que comprende proteínas de la membrana exterior de histophilus somni; usos y sus métodos de preparación.

Country Status (17)

Country Link
US (1) US9597386B2 (es)
EP (1) EP2833912A1 (es)
JP (1) JP2015519305A (es)
KR (1) KR20150003269A (es)
CN (1) CN104470539A (es)
AR (2) AR090613A1 (es)
AU (1) AU2013243622A1 (es)
BR (1) BR112014024491A2 (es)
CA (1) CA2866888A1 (es)
CL (1) CL2014002658A1 (es)
CO (1) CO7160028A2 (es)
EA (1) EA201401078A1 (es)
MX (1) MX2014012013A (es)
PH (1) PH12014502223A1 (es)
SG (1) SG11201406209WA (es)
UY (1) UY34733A (es)
WO (1) WO2013151979A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809283A1 (en) * 2011-11-10 2013-05-10 Dokdo Co., Ltd. Heating container
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof
KR102304838B1 (ko) * 2014-02-07 2021-09-28 바스프 에스이 개선된 바이오매스 분리 거동을 갖는 변형된 미생물
US9592283B2 (en) * 2014-03-25 2017-03-14 Merial, Inc. Immunological compositions containing attenuated Histophilus somni
KR101960016B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법
KR101960017B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
WO1993021323A1 (en) 1992-04-09 1993-10-28 University Of Saskatchewan Haemophilus somnus immunogenic proteins
US6100066A (en) 1992-04-09 2000-08-08 University Of Saskatchewan Nucleic acid molecules encoding Haemophilus somnus proteins
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
CA2347278C (en) 1998-09-25 2007-07-17 Lynette B. Corbeil Vaccine based on attenuated haemophilus somnus
JP2004222593A (ja) * 2003-01-23 2004-08-12 National Agriculture & Bio-Oriented Research Organization 反芻獣病原細菌の主要外膜タンパク質をコードする遺伝子
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof

Also Published As

Publication number Publication date
CN104470539A (zh) 2015-03-25
AU2013243622A1 (en) 2014-09-25
US9597386B2 (en) 2017-03-21
US20130266613A1 (en) 2013-10-10
WO2013151979A1 (en) 2013-10-10
EA201401078A1 (ru) 2015-04-30
PH12014502223A1 (en) 2015-01-12
AR090624A1 (es) 2014-11-26
JP2015519305A (ja) 2015-07-09
CO7160028A2 (es) 2015-01-15
BR112014024491A2 (pt) 2017-08-08
UY34733A (es) 2013-10-31
KR20150003269A (ko) 2015-01-08
SG11201406209WA (en) 2014-10-30
MX2014012013A (es) 2014-11-25
CA2866888A1 (en) 2013-10-10
AR090613A1 (es) 2014-11-26
EP2833912A1 (en) 2015-02-11

Similar Documents

Publication Publication Date Title
CL2014002658A1 (es) Composición inmunogénica que comprende proteínas de la membrana exterior de histophilus somni; usos y sus métodos de preparación.
CL2014002903A1 (es) Composición geopolimérica de aluminosilicato; método de preparacion y sus usos.
DOP2010000364A (es) Vacuna de vesicula de membrana externa nativa multivalente del miningococo metodo para su fabricacion y uso
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
BR112012026162A2 (pt) método, meio e sistema para rederização tridimensional de uma área visível tridimensional
CO6781540A2 (es) Protéinas de fusión y vacunas de combinación que comprenden proteína e y pilina a de haemophilus influenzae
BR112013011705A2 (pt) antígenos consensuais de próstata, molécula de ácido nucleico que os codificam e vacina e usos que os compreendem
CL2014002954A1 (es) Composicion farmaceutica que contiene anticuerpos anti-il-23p19 y sus usos.
BR112014031828A2 (pt) preparação, usos e formas sólidas de ácido obeticólico
EP3077091A4 (en) Nanofiltration membranes and methods of use
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
BR112014004213A2 (pt) novas moléculas de fusão kif5b-ret e usos das mesmas
CO7091189A2 (es) Microemulsiones y sus usos como sistemas de administración
DK2643029T3 (da) Præparat og/eller formulering af proteiner, som er tværbundet med polysaccharider
BR112012028592A2 (pt) método para fabricação de uma composição de glicosaminoglicano, composição de glicosaminoglicano, seus usos e preparação adequada para aplicação à pele ou membrana mucosa
BR112013030395A2 (pt) polipeptídeo, polinucleotídeo, vetor, composição imunogênica, vacina, e, uso de uma composição imunogênica
DK2920240T3 (da) Fremgangsmåde til fremstilling af en vandig opløsning af chitosan, chitosansammensætning, chitosanaerosol, fremgangsmåde til fremstilling af en chitosanhydrogelmembran og fremgangsmåde til fremstilling af et chitosan-protein-biopolymermateriale
DK2588620T3 (da) Fremgangsmåde til fremstilling af butanol eller acetone
ES2982229T3 (es) Membrana porosa isótropa y método de preparación de la misma
BR112015022347A2 (pt) composição para vacinação, método para produzir uma composição para vacinação e uso de composição
EP3059293A4 (en) DISPERSED ZIRCONIUM PARTICLE GEL COMBINATION FLUX SYSTEM AND METHOD FOR PREPARING THE SAME
BR112015002456A2 (pt) conduto flexível submarino , processo de preparação do conduto flexível submarino, uso de um conduto flexível submarino e uso de um polietileno
BR112013013179A2 (pt) polimorfos de nor-udca ou bis-nor-udca, seu uso e método de preparação, bem como composições farmacêuticas que os compreendem
CL2015001659A1 (es) Composición inmunogénica que comprende antígenos de mycoplasma
CL2015001618A1 (es) Adyuvante de vacunación, preparación y vacunas que lo contienen